[APDN] Applied DNA Sciences Inc

Overview

Type of security: Stock

Sector: Consumer Services

Industry: Other Consumer Services

Market Capitalization: 77.3 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 2 Change: -0.05 (-2.44%)
Ext. hours: Change: 0 (0%)

chart APDN

Refresh chart

Strongest Trends Summary For APDN

APDN is in the long-term down -48% below S&P in 2 years and down -69% below S&P in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Applied DNA Sciences, Inc. provides botanical-DNA based anti-counterfeiting and product authentication solutions for supply chain security, brand protection, and law enforcement applications in the United States, Europe, and Asia. The company offers SigNature DNA markers for embedment into a range of media, such as inks, dyes, textile treatments, thermal ribbon thread, laminates, glues, threads, varnishes, adhesives, and metal coatings; SigNature T botanical DNA markers for use in brand protection efforts and raw material source compliance programs; and SmartDNA, a patented security system for stores, warehouses, banks, pharmacies, and ATMs, as well as for the protection of valuables. It also provides DNANet tactical DNA products for law enforcement in the form of DNA-marked fixative sprays and liquids; digitalDNA, a DNA-secured form of the quick read code to create customer interface; fiberTyping solution, which is used in DNA verification for manufacturers, retailers, and brand owners to ensure quality, saf

Fundamental Ratios
Shares Outstanding24.08 M EPS-0.53 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 80.62% Sales Growth - Q/Q22.3% P/E-1.89
P/E To EPS Growth P/S18.2 P/BV39.54 Price/Cash Per Share
Price/Free Cash Flow-8.84 ROA-378.83% ROE-702.45% ROI
Current Ratio1.38 Quick Ratio Long Term Debt/Equity Debt Ratio0.85
Gross Margin Operating Margin-259.56% Net Profit Margin-323.45% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities3.8 M Cash From Investing Activities-230 K Cash From Operating Activities-3.97 M Gross Profit
Net Profit-1.89 M Operating Profit-1.88 M Total Assets3.63 M Total Current Assets2.3 M
Total Current Liabilities1.67 M Total Debt Total Liabilities1.67 M Total Revenue1.52 M
Technical Data
High 52 week2.68 Low 52 week1.11 Last close1.12 Last change-4.27%
RSI16.67 Average true range0.09 Beta0.35 Volume207.81 K
Simple moving average 20 days-17.19% Simple moving average 50 days-13.63% Simple moving average 200 days-20.54%
Performance Data
Performance Week-9.68% Performance Month-24.83% Performance Quart-18.84% Performance Half-25.33%
Performance Year-54.47% Performance Year-to-date-29.56% Volatility daily3.32% Volatility weekly7.43%
Volatility monthly15.24% Volatility yearly52.78% Relative Volume261.52% Average Volume146.41 K
New High New Low

News

2019-03-01 10:35:22 | Applied DNA Sciences, Inc. NASDAQ:APDN Insiders Increased Their Holdings

2019-03-01 05:00:00 | Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates

2019-02-12 05:00:00 | Applied DNA Signs Term Sheet with TheraCann International for Exclusive License of CertainT® Platform in Legal Cannabis and Hemp

2019-02-08 22:11:50 | Edited Transcript of APDN earnings conference call or presentation 7-Feb-19 9:30pm GMT

2019-02-07 18:02:33 | Applied DNA Sciences: Fiscal 1Q Earnings Snapshot

2019-02-07 16:05:00 | Applied DNA Reports Fiscal First Quarter 2019 Financial Results

2019-02-06 15:46:00 | Joint Applied DNA/TheraCann’s Cannabis Seed-to-Sale Solution Positioned Towards Europe, Africa and Asia Markets by Israel Cannabis iCAN

2019-01-31 05:00:00 | Applied DNA Schedules Fiscal 2019 First Quarter Financial Results Conference Call for Thursday, February 7, 2019 at 4:30 PM ET

2019-01-29 05:00:00 | Applied DNA Appoints Stephen Birkhold to the Strategic Advisory Board

2019-01-28 05:00:00 | Applied DNA Signs MOU with Tex-Ray Industrial to Introduce CertainT® Authentication Platform to Global Textile Brands

2019-01-24 05:00:00 | Applied DNA Signs Memorandum of Understanding with Sun Chemical Supply Company to Bring CertainT® Authentication Platform to Textile Manufacturers in Asia

2018-12-27 16:05:00 | Applied DNA Announces Closing of $2.75 Million Public Offering of Common Stock and Warrants

2018-12-21 08:30:00 | Applied DNA Announces Pricing of $2.75 Million Offering of Common Stock and Warrants

2018-12-19 16:06:00 | Applied DNA Announces Proposed Public Offering of Common Stock and Warrants

2018-12-13 07:30:44 | Applied DNA Sciences: Fiscal 4Q Earnings Snapshot

2018-12-13 07:00:00 | Applied DNA Announces Selected Preliminary Unaudited Fiscal 2018 Year End and Fourth Quarter Financial Results

2018-12-10 05:00:00 | Applied DNA Signs Joint Development Agreement with Everledger to Develop and Market a CertainT®-Enhanced, Blockchain-Based Platform for Provenance Verification

2018-12-06 08:30:00 | Applied DNA to Participate at Cannabis Capital Forum on December 7

2018-12-04 12:28:00 | LineaRx to Hold Analyst Day Webinar to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy

2018-12-01 08:59:26 | What Type Of Shareholder Owns Applied DNA Sciences Inc’s NASDAQ:APDN?

2018-11-26 05:00:00 | Applied DNA’s SigNature® DNA Evidence Helps to Convict Over 131 Criminals to Date

2018-11-21 08:00:00 | Long Island Capital Alliance to Hold Cannabis Capital Forum on December 7, 2018

2018-11-19 09:12:00 | Applied DNA and Eurofins BLC Sign Collaboration Agreement to Support Commercial Implementation of Leather Traceability System

2018-11-15 07:20:00 | Analysis: Positioning to Benefit within Red Lion Hotels, P.A.M. Transportation Services, Champions Oncology, Kingstone Companies, Applied DNA Sciences, and Innodata — Research Highlights Growth, Revenue, and Consolidated Results

2018-11-07 08:30:00 | Applied DNA Subsidiary LineaRx Provides Cost and Quality Advantages to Technogenetics Diagnostic Solutions

2018-11-05 08:30:00 | New Study: DNA Molecular Tagging is an Effective Tool to Authenticate Denim, One of the Toughest Fabrics

2018-10-29 05:00:00 | GHCL, a Global Home Textiles Player, Creates “CIRKULARITY”, a Brand Platform, Inspired By “REKOOP” Sustainable, Traceable, Recycled Polyester Bedding

2018-10-24 05:00:00 | Applied DNA Enters FY2019 with Strong Business Momentum

2018-10-16 05:00:00 | Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-Viral, Plasmid-Free CAR T Manufacturing Platform

2018-10-04 05:00:00 | Applied DNA Appoints Industry Veteran Wayne Buchen Vice President of Strategic Sales for Textile Vertical

2018-10-01 05:00:00 | LineaRx Secures New RNA Therapeutics Customers for Contract Research Services

2018-09-25 05:00:00 | Applied DNA Expands Cannabis Tagging Portfolio to Address Large Growers

2018-09-20 05:00:00 | Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines

2018-09-18 07:14:00 | Applied DNA Forms Wholly Owned Subsidiary, LineaRx, to Develop Large-Scale, PCR-Produced DNA for Biotherapeutics

2018-09-11 05:00:00 | Applied DNA Executes New Two-Year Contract with the U.S. Defense Logistics Agency

2018-09-04 05:00:00 | Applied DNA Announces $1.65 Million Private Placement of Secured Convertible Notes

2018-08-27 05:00:00 | Applied DNA Presenting Linear DNA for Gene Therapy at Boston Immuno-Oncology Summit

2018-08-13 23:29:39 | Edited Transcript of APDN earnings conference call or presentation 13-Aug-18 8:30pm GMT

2018-08-13 16:11:36 | Applied DNA Sciences: Fiscal 3Q Earnings Snapshot

2018-08-13 16:05:00 | Applied DNA Reports Fiscal Third Quarter 2018 Financial Results

2018-08-13 14:30:00 | Applied DNA Sciences, Inc. to Host Earnings Call

2018-08-06 05:30:00 | Applied DNA Schedules Fiscal 2018 Third Quarter Financial Results Conference Call for Monday, August 13, 2018 at 4:30 PM ET

2018-08-02 05:30:00 | Applied DNA Sciences Reaches New Milestones in Therapeutic Contract Research and Contract Manufacturing of Linear DNA

2018-08-01 11:56:00 | TheraCann Launches ETCH Biotrace™ Technology

2018-07-31 03:30:00 | Applied DNA Signs MOU with Everledger to Build CertainT® Blockchain Platform for High-end Product Markets

2018-07-26 05:30:00 | Majority of American Consumers Concerned About Inauthentic Products; 73% Would Stop Purchases

2018-07-24 05:00:00 | Applied DNA, TheraCann International to Introduce Cannabis Tagging System CTS at the NCIA Cannabis Business Summit & Expo July 25-27

2018-07-17 05:30:00 | Applied DNA Ships $1.15 Million Order in Fiscal 2018 Third Quarter to Tag Initial Cotton Harvest

2018-07-11 06:00:00 | UL and Applied DNA Announce Strategic Partnership

2018-05-05 07:55:26 | Edited Transcript of APDN earnings conference call or presentation 3-May-18 8:30pm GMT